Structure, Classification, and Naming of Therapeutic Monoclonal Antibodiesautoimmune diseasescancer cellsclinical practicecytotoxic agentglembatumumab vedotinmodern biotherapeuticspolypeptide chainstherapeutic monoclonal antibodiesdoi:10.1002/9781118940648.CH2Z. Xia...
Summary Therapeutic monoclonal antibodies (mAbs) have become the cornerstone in the clinical practice of modern biotherapeutics, especially in oncology, inflammation, and autoimmune diseases. A cytotoxic agent can be linked to an antitumor antibody for drug targeting purposes. The word vedotin, for ...